Skip to content
Home/Companies/HealthTech/Visiopharm

Visiopharm

HealthTech·Denmark·Exited 2026·Held 11yr
Entry
2015
Hold
11yr
Exit
2026

Who owns Visiopharm?

Visiopharm is a Danish HealthTech company, now owned by Grundium, which acquired it in 2026 from Northcap.

Hand-verified · updated 2026-08-19

Open JSON · CC-BY
Northcap
Investor
Northcap
Northcap III · 2011 · VC

Key facts

HQDenmark
SectorHealthTech
StatusAcquired
Exit Type
Trade Sale
Buyer
Grundium
Exit Year
2026

More from Northcap III

Other portfolio companies in the same fund.

GAN Integrity
GAN Integrity
Exited 2023
SaaSDenmark· 2017
to Apax Partners
Linkfire
Exited 2021
SaaSDenmark· 2015
Sekoia
Exited 2024
HealthTechDenmark· 2015
to KMD
Falcon.io
Exited 2019
SaaSDenmark· 2012
to Cision

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Visiopharm?

Visiopharm is now owned by Grundium, which acquired it in 2026 from Northcap.

When did Grundium acquire Visiopharm?

Grundium acquired Visiopharm in 2026, buying from Northcap.

Who did Visiopharm sell to?

Northcap sold Visiopharm to Grundium in 2026 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue